[Results of the use of dalargin electrophoresis to correct mental disorders in patients with hypertension grades I and II].
Dalargin, a small regulatory peptide produced in the USSR was tested with respect to its effect on psychological indices in 80 patients with essential hypertension grades I and II. Endonasal Dalargin electrophoresis was applied in 50 patients and 30 were subjected to endonasal galvanization (the control group). Electrophoretically applied Dalargin was shown to accelerate the sensorimotor responses, improve memory, reduce the anxiety levels.
Ezhov
V A
VA
Buiavykh
A G
AG
D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000209:etiology; D004743:Enkephalin, Leucine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000523:psychology*; D007478:Iontophoresis; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology
D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Rezul'taty primeneniia dalargin-élektroforeza s tsel'iu korrektsii psikhicheskogo sostoianiia bol'nykh gipertonicheskoĭ bolezn'iu I i II stadiĭ.